 |
Top 18 Multiple Sclerosis startups
Sep 28, 2025 | By Jason Kwon | 20 |
These startups develop new Multiple Sclerosis treatments and diagnostics technologies, like AI-powered drug-discovery, gene therapy, stem cells, cerebrospinal fluid analysis, evoked potential testing.
1
Country: USA | Funding: $535.8M
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, multiple sclerosis (MS).
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, multiple sclerosis (MS).
2
Country: Israel | Funding: $210.6M
ReWalk Robotics is an innovative medical device company that is designing, developing and commercializing exoskeletons allowing wheelchair-bound individuals to stand and walk once again. Our mission is to fundamentally change the Quality of Life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
ReWalk Robotics is an innovative medical device company that is designing, developing and commercializing exoskeletons allowing wheelchair-bound individuals to stand and walk once again. Our mission is to fundamentally change the Quality of Life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
3
Country: USA | Funding: $183M
Sudo Biosciences is a biopharmaceutical company committed to developing cutting-edge medications that are unmatched in their class that advances programs in multiple sclerosis and psoriasis
Sudo Biosciences is a biopharmaceutical company committed to developing cutting-edge medications that are unmatched in their class that advances programs in multiple sclerosis and psoriasis
4
Country: USA | Funding: $142.1M
Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.
Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.
5
Country: USA | Funding: $135.5M
The Cour particle platforms provide a novel and highly specific immune targeting capability which may be safely applied to severe inflammatory modulation, and immune (antigen) tolerization.
The Cour particle platforms provide a novel and highly specific immune targeting capability which may be safely applied to severe inflammatory modulation, and immune (antigen) tolerization.
6
Country: USA | Funding: $70M
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.
7
Country: Switzerland | Funding: $54.6M
GeNeuro develops innovative treatments against inflammatory and degenerative disorders associated with endogenous retroviruses.
GeNeuro develops innovative treatments against inflammatory and degenerative disorders associated with endogenous retroviruses.
8
Country: Denmark | Funding: $38M
Dawn Health is a digital health company specializing in developing regulated software-as-a-medical-device and digital therapeutics, used in oncology and for multiple sclerosis and rare pediatric conditions, like growth disorders
Dawn Health is a digital health company specializing in developing regulated software-as-a-medical-device and digital therapeutics, used in oncology and for multiple sclerosis and rare pediatric conditions, like growth disorders
9
Country: USA | Funding: $15.7M
28bio's Nerve-on-a-Chip platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
28bio's Nerve-on-a-Chip platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
10
Country: Spain | Funding: €5.1M
Bionure Farma develops innovative therapies for the treatment of orphan ophthalmology diseases and multiple sclerosis.
Bionure Farma develops innovative therapies for the treatment of orphan ophthalmology diseases and multiple sclerosis.
11
Country: Switzerland | Funding: 3
ReHaptix is a clinically validated mHealth application assisting patients and healthcare professionals in monitoring the rehabilitation progress of patients suffering from upper limb impairments caused by a neurological injury, such as stroke, multiple sclerosis or Parkinson's disease.
ReHaptix is a clinically validated mHealth application assisting patients and healthcare professionals in monitoring the rehabilitation progress of patients suffering from upper limb impairments caused by a neurological injury, such as stroke, multiple sclerosis or Parkinson's disease.
12
Country: USA
BeCare Link connects patients to physicians and researchers, through the use of a user-friendly mobile app, to provide unprecedented levels of insight about MS and other neurodegenerative diseases.
BeCare Link connects patients to physicians and researchers, through the use of a user-friendly mobile app, to provide unprecedented levels of insight about MS and other neurodegenerative diseases.
13
Country: Russia
Innovative startup for the analysis and diagnosis of multiple sclerosis. Provides cloud service for analyzing MS lesions powered by artificial intelligence
Innovative startup for the analysis and diagnosis of multiple sclerosis. Provides cloud service for analyzing MS lesions powered by artificial intelligence
★
See also:
